A 1-year, randomized, double-blind safety study of long-term treatment of a new gel formulation containing calcipotriene plus betamethasone dipropionate in scalp psoriasis

被引：0
|
作者：
Luger, Thomas [1 ]
Kidson, Paul [2 ]
Cambazard, Francois [3 ]
Larsen, Frederik Gronhoj [4 ]
机构：
[1] Univ Clin Munster, Munster, Germany
[2] LEO Pharma inc, Thornhill, ON, Canada
[3] CHU ST Etiene, Hop Nord, St Etienne, France
[4] Dermatol Practice, Frederiksberg, Denmark
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2008年 / 58卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB134 / AB134
页数：1
相关论文
共 50 条
  • [1] A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: A randomized, double-blind, controlled trial
    Jemec, Gregor B. E.
    Ganslandt, Cecilia
    Ortonne, Jean-Paul
    Poulin, Yves
    Burden, A. David
    de Unamuno, Pablo
    Berne, Berit
    Figueiredo, Americo
    Austad, Joar
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (03) : 455 - 463
  • [2] A Study of the Safety and Efficacy of Calcipotriol and Betamethasone Dipropionate Scalp Formulation in the Long-Term Management of Scalp Psoriasis
    Luger, T. A.
    Cambazard, F.
    Larsen, F. G.
    Bourcier, M.
    Gupta, G.
    Clonier, F.
    Kidson, P.
    Shear, N. H.
    DERMATOLOGY, 2008, 217 (04) : 321 - 328
  • [3] A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial
    van de Kerkhof, P. C. M.
    Hoffmann, V.
    Anstey, A.
    Barnes, L.
    Bolduc, C.
    Reich, K.
    Saari, S.
    Segaert, S.
    Vaillant, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (01) : 170 - 176
  • [4] Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial
    Kragballe, K.
    Hoffmann, V.
    Ortonne, J. P.
    Tan, J.
    Nordin, P.
    Segaert, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (01) : 159 - 166
  • [5] Calcipotriene Plus Betamethasone Dipropionate Topical Suspension for the Treatment of Mild to Moderate Psoriasis Vulgaris on the Body: A Randomized, Double-Blind, Vehicle-Controlled Trial
    Menter, Alan
    Gold, Linda Stein
    Bulchalo, Michael
    Grekin, Steven
    Kempers, Steven
    Boyce, Brent M.
    Ganslandt, Cecilia
    Villumsen, John
    Lebwohl, Mark
    JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (01) : 92 - 98
  • [6] A calcipotriene/betamethasone dipropionate two-compound scalp formulation in the treatment of scalp psoriasis in Hispanic/Latino and Black/African American patients: results of the randomized, 8-week, double-blind phase of a clinical trial
    Tyring, Stephen
    Mendoza, Natalia
    Appell, Melanie
    Bibby, Adrian
    Foster, Richard
    Hamilton, Tiffani
    Lee, Mark
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2010, 49 (11) : 1328 - 1333
  • [7] A randomized, double-blind, parallel group, dose-ranging comparison of the efficacy and safety of calcipotriene solution in the treatment of scalp psoriasis
    Carder, KR
    Smith, SL
    Hillson, EM
    Stiller, MJ
    Kollias, N
    Gillies, R
    Siskin, SB
    Drake, LA
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 844 - 844
  • [8] Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese population
    Ma, Li
    Yang, Qinping
    Yang, Haizhen
    Wang, Gang
    Zheng, Min
    Hao, Fei
    Gu, Jun
    Sun, Qiuning
    Cui, Pangen
    Ge, Mengliang
    Li, Ruoyu
    Gao, Tianwen
    Facy, Patrice
    Kurvits, Merle
    Xu, Zhenyi
    Xu, Jinhua
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2016, 55 (01) : 106 - 113
  • [9] Comparison of safety and efficacy between calcipotriol plus betamethasone dipropionate gel and calcipotriol scalp solution as long-term treatment for scalp psoriasis in Chinese patients: a national, multicentre, prospective, randomized, active-controlled phase 4 trial
    Liu, Lunfei
    Zhang, Chunlei
    Wang, Jinyan
    Chen, Kun
    Ding, Yangfeng
    Yan, Guofu
    Lu, Qianjin
    Li, Wei
    Fang, Hong
    Cheng, Hao
    Zhang, Jianzhong
    He, Yanling
    Zhu, Wei
    Lu, Yan
    Huang, Jinhua
    Pan, Weili
    Li, Ming
    Cao, Shuanglin
    Li, Shanshan
    Han, Xiuping
    He, Li
    Chen, Yayuan
    Zheng, Min
    EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (05) : 580 - 590
  • [10] A Multicenter, Randomized, Double-Blind Study of the Efficacy and Safety of Calcipotriene Foam, 0.005%, vs Vehicle Foam in the Treatment of Plaque-type Psoriasis of the Scalp
    Feldman, Steven R.
    Eastman, William J.
    Brundage, Thomas
    Mills, Mary
    JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (03) : 300 - 306
12345